Treatment of massive gastrointestinal bleeding occurred during autologous stem cell transplantation with recombinant activated factor VII and octreotide

ATAŞ, Erman; Kesik, Vural; GÜRSEL, Orhan

doi:10.4103/0973-1482.138106

Treatment of massive gastrointestinal bleeding occurred during autologous stem cell transplantation with recombinant activated factor VII and octreotide

ATAŞ E., Kesik V., GÜRSEL O.

Journal of Cancer Research and Therapeutics, cilt.11, sa.3, ss.667, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 11 Sayı: 3
Basım Tarihi: 2015
Doi Numarası: 10.4103/0973-1482.138106
Dergi Adı: Journal of Cancer Research and Therapeutics
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.667
Anahtar Kelimeler: Gastrointestinal bleeding, octreotide, recombinant activated factor VII
Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

After hematopoietic stem cell transplantation (HSCT), patients may suffer from bleeding. One of the bleeding type is gastrointestinal (GI) which has serious morbidity and mortality in children with limited treatment options. Herein, we presented a child with upper GI bleeding post autologous HSCT controlled successfully by using recombinant activated factor VII (rFVIIa) and octreotide infusion.